We are live on ! Find out more
IMCR icon

Immunocore

41 hedge funds and large institutions have $598M invested in Immunocore in 2021 Q1 according to their latest regulatory filings, with 41 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

34.04% more ownership

Funds ownership: 0%34.04% (+34%)

Holders
41
Holders Change
+41
Holders Change %
% of All Funds
0.72%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.05%
New
41
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
SFM
26
Sphera Funds Management
Israel
$1.53M +$1.6M +36,000 New
Alyeska Investment Group
27
Alyeska Investment Group
Illinois
$1.49M +$1.56M +35,000 New
TD Asset Management
28
TD Asset Management
Ontario, Canada
$1.17M +$1.22M +27,506 New
PCM
29
Pinz Capital Management
New York
$796K +$833K +18,700 New
Morgan Stanley
30
Morgan Stanley
New York
$648K +$677K +15,207 New
CCM
31
CAAS Capital Management
New York
$639K +$668K +15,000 New
EMG
32
ETF Managers Group
New Jersey
$571K +$588K +13,211 New
UBS Group
33
UBS Group
Switzerland
$497K +$520K +11,673 New
AFM
34
Anson Funds Management
Texas
$426K +$445K +10,000 New
Victory Capital Management
35
Victory Capital Management
Texas
$426K +$445K +10,000 New
ZP
36
Zimmer Partners
New York
$426K +$445K +10,000 New
LCM
37
Laurion Capital Management
New York
$213K +$223K +5,000 New
RCMU
38
Rokos Capital Management (UK)
United Kingdom
$21K +$22.3K +500 New
Osaic Holdings
39
Osaic Holdings
Arizona
$5K +$5.43K +122 New
Bank of America
40
Bank of America
North Carolina
$4K +$4.45K +100 New
HI
41
Harbour Investments
Wisconsin
$1K +$1.11K +25 New

IMCR Hedge Fund Activity: Q1 2021 in Review

41 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Immunocore (IMCR) for Q1 2021, worth a combined $598M.

Buyers outnumbered sellers: 41 funds opened new IMCR positions and 0 closed out — a net gain of 41 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Baker Bros. Advisors, opening a new position worth an estimated $112M.

  • 41 institutional investors held Immunocore (IMCR) as of Q1 2021, up from 0 in Q4 2020.
  • Funds reported $598M of Immunocore stock for Q1 2021.
  • 41 funds opened new Immunocore positions in Q1 2021 and 0 closed out, a net change of +41 holders.
  • The largest Immunocore buyer in Q1 2021 was Baker Bros. Advisors, an estimated $112M added.

Based on aggregated 13F filings for Q1 2021.